UBIS (Asia) PCL (BKK:UBIS-R) Current Accrued Expense: ฿0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:UBIS-R UBIS (Asia) PCL BKK:UBIS-R
65 GF Score
Price ฿1.69
GF Value ฿1.58
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is UBIS (Asia) PCL Current Accrued Expense?

UBIS (Asia) PCL BKK:UBIS-R +68.97% 65 Current Accrued Expense is ฿0.0 Mil as of Jun. 2026. GuruFocus rates BKK:UBIS-R with a GF Score™ of 65/100 and a GF Value™ of ฿1.58 (Fairly Valued). The stock has 7 warning signs investors should review.

UBIS (Asia) PCL's Current Accrued Expense for the quarter that ended in Jun. 2026 was ฿0.0 Mil.

UBIS (Asia) PCL's quarterly Current Accrued Expense declined from Dec. 2025 (฿21.4 Mil) to Mar. 2026 (฿0.0 Mil) but then stayed the same from Mar. 2026 (฿0.0 Mil) to Jun. 2026 (฿0.0 Mil).

UBIS (Asia) PCL's annual Current Accrued Expense declined from Dec. 2023 (฿14.2 Mil) to Dec. 2024 (฿13.7 Mil) but then increased from Dec. 2024 (฿13.7 Mil) to Dec. 2025 (฿21.4 Mil).

UBIS (Asia) PCL Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for UBIS (Asia) PCL's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UBIS (Asia) PCL Current Accrued Expense Chart

UBIS (Asia) PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.68 16.41 14.16 13.75 21.42

UBIS (Asia) PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 21.42 0.00 0.00
BKK:UBIS-R
65GF Score
UBIS (Asia) PCL BKK:UBIS-R
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UBIS (Asia) PCL Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of ฿0.0 Mil mean?
UBIS (Asia) PCL (BKK:UBIS-R) has a Current Accrued Expense of ฿0.0 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on UBIS (Asia) PCL and its competitors.
Is UBIS (Asia) PCL's Current Accrued Expense too high?
UBIS (Asia) PCL's current Current Accrued Expense is ฿0.0 Mil. Overall, UBIS (Asia) PCL has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UBIS (Asia) PCL's Current Accrued Expense compare to LIN and SHW?
UBIS (Asia) PCL's Current Accrued Expense of ฿0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Chemicals company?
A good Current Accrued Expense depends on the Chemicals industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on UBIS (Asia) PCL and its competitors. UBIS (Asia) PCL's current Current Accrued Expense is ฿0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UBIS (Asia) PCL stock overvalued right now?
Based on GuruFocus' analysis, UBIS (Asia) PCL (BKK:UBIS-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿1.58, compared to a current price of ฿1.69 — trading 6.9% above its estimated fair value. The current Current Accrued Expense is ฿0.0 Mil. UBIS (Asia) PCL's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For UBIS (Asia) PCL (BKK:UBIS-R), the current Current Accrued Expense is ฿0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UBIS (Asia) PCL (BKK:UBIS-R) Overvalued in 2026?

Based on GuruFocus' analysis, UBIS (Asia) PCL stock appears to be overvalued. The current stock price of ฿1.69 is trading 6.9% above its estimated GF Value™ of ฿1.58. GuruFocus considers UBIS (Asia) PCL to be Fairly Valued.

Key valuation signals for BKK:UBIS-R:

  • Current Accrued Expense: ฿0.0 Mil
  • GF Value™: ฿1.58 vs. price of ฿1.69 (6.9% above fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the BKK:UBIS-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UBIS (Asia) PCL Business Description

Other Exchanges UBIS:Thailand
Address Naradhiwas Rajanagarindra Road, No. 238, 15th Floor, Unit 4-6, TRR Tower, Chong Nonsi Subdistrict, Yannawa District, Bangkok, THA, 10120
UBIS (Asia) PCL is engaged in the business of manufacturing and distributing of sealing compounds, lacquers, and coatings used in can production and bottle closure for the food, beverage, and general industries. It operates in two business segments, each offering different products and services: Manufacturer and distributor of sealing compounds, lacquers and coatings and Other business The majority of the revenue is generated from the Manufacturer of sealing compounds, lacquers and coatings segment. Company operates in Thailand, China, and Others, with the majority of revenue from Other segment.
65GF Score

Get the complete analysis for BKK:UBIS-R

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.69
Price
฿1.58
GF Value